Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 11 of 11 entries
View as:

A Phase 3, Multi-Center Study Evaluating PL9643 in Patients with Dry Eye

Phase: N/A Priority: Normal
NCT ID: NCT05201170 Org: User:
Start: 12/30/21 End: 11/21/23 Due: 11/21/24

2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder

Phase: N/A Priority: Normal
NCT ID: NCT02338960 Org: User:
Start: 01/31/15 End: 06/29/17 Due: 06/29/18

Cross-Over Study of Subcutaneous Study Drug for the Treatment of Patients With Mild to Moderate Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01304628 Org: User:
Start: - End: - Due: -

Safety Study of Subcutaneously Administered PL-3994 in Subjects With Controlled Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00686803 Org: User:
Start: 04/30/08 End: 07/31/08 Due: 07/31/09

1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder

Phase: N/A Priority: Normal
NCT ID: NCT02333071 Org: User:
Start: 12/31/14 End: 06/30/17 Due: 06/30/18

Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)

Phase: N/A Priority: Normal
NCT ID: NCT00425256 Org: User:
Start: 02/28/06 End: 05/31/07 Due: 05/31/08

Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01382719 Org: User:
Start: 06/30/11 End: 09/30/12 Due: 09/30/13

A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity

Phase: N/A Priority: Normal
NCT ID: NCT06565611 Org: User:
Start: 08/05/24 End: 03/31/25 Due: 03/31/26

Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04318145 Org: User:
Start: 11/12/20 End: 03/31/23 Due: 03/31/24

A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT05709444 Org: User:
Start: 12/26/22 End: 04/26/24 Due: 04/26/25

Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)

Phase: N/A Priority: Normal
NCT ID: NCT05466890 Org: User:
Start: 09/15/22 End: 03/31/25 Due: 03/31/26